Summary
The product PARAMED 76.5, manufactured by DEUS Medical and submitted by DEUSPOWER.SHOP, underwent qualitative and quantitative analysis of AAS oil. The analysis conducted by Janoshik Analytical confirmed the sample as containing Trenbolone Hexahydrobenzylcarbonate.
The sample was ordered for testing on 5 January 2021, received on 6 January 2021, and analyzed the same day.
Detailed Report
Product Overview
- Manufacturer: DEUS Medical
- Product Name: PARAMED 76.5
- Active Ingredient: Trenbolone Hexahydrobenzylcarbonate
- Batch Number: FU37190; Mfg. 11/2020
- Expiration Date: Not provided
- Delivery Method: Injectable AAS oil
Sample Acquisition and Testing
- Task Number: #09568
- Testing Ordered: 5 January 2021
- Sample Received: 6 January 2021
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: DEUSPOWER.SHOP
- Analysis Paid For By: DEUSPOWER.SHOP
Testing Results
| Compound | Measured Concentration (mg/ml) |
|---|---|
| Trenbolone Hexahydrobenzylcarbonate | 76.25 mg/ml |
Verification Details
- Verification URL: https://janoshik.com/tests/09568_P1GF4HAM76VP
Evaluation of Reseller-Submitted Testing
The tested sample demonstrates a precise and high concentration of Trenbolone Hexahydrobenzylcarbonate. The concentration of 76.25 mg/ml aligns with expected dosage levels for a product marketed at 76.5 mg/ml.
Conclusion
The tested batch of PARAMED 76.5 shows a reliable formulation with a concentration consistent with the intended product specifications.
Disclaimer
This report is intended for educational and harm-reduction purposes. Reseller-submitted testing can provide valuable insights but may reflect selective sampling. Consumers are encouraged to make informed decisions and consider further independent analysis.
